MicroRNA-30b/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Zhong, Keng ^a   Chen, Kun ^b   Han, Lin ^a   Li, Bailing ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b People's Hospital of Tongren City   (China)

Author keywords

miR 30b; miR 30c; NSCLC; Proliferation; Rab18

Indexed keywords

DNA; MESSENGER RNA; MICRORNA; MICRORNA 30B; MICRORNA 30C; RAB PROTEIN; RAB18 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; MIRN30 MICRORNA, HUMAN; RAB18 PROTEIN, HUMAN;

ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUCIFERASE ASSAY; MTT ASSAY; NON SMALL CELL LUNG CANCER; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; CHEMISTRY; GENETICS; LUNG TUMOR; NUCLEOTIDE SEQUENCE; PATHOLOGY; REPORTER GENE; RNA INTERFERENCE; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION; GENES, REPORTER; HUMANS; LUNG NEOPLASMS; MICRORNAS; RAB GTP-BINDING PROTEINS; RNA INTERFERENCE;

EID: 84907401734     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-703     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
2. Wood AJJ, Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med 2004, 350(4):379-392. 10.1056/NEJMra035536, 14736930.
3. Yang L, Parkin DM, Ferlay J, Li L, Chen Y. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomark Prev 2005, 14(1):243-250.
4. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127(12):2893-2917. 10.1002/ijc.25516, 21351269.
5. Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol 2008, 9(3):219-230. 10.1038/nrm2347, 18270516.
6. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79:351-379. 10.1146/annurev-biochem-060308-103103, 20533884.
7. Zhao J-J, Yang J, Lin J, Yao N, Zhu Y, Zheng J, Xu J, Cheng JQ, Lin J-Y, Ma X. Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis. Childs Nerv Syst 2009, 25(1):13-20. 10.1007/s00381-008-0701-x, 18818933.
8. Hassan O, Ahmad A, Sethi S, Sarkar FH. Recent updates on the role of microRNAs in prostate cancer. J Hematol Oncol 2012, 5(9):13. 3342163, 22453030.
9. Du L, Pertsemlidis A. microRNA regulation of cell viability and drug sensitivity in lung cancer. Expert Opin Biol Ther 2012, 12(9):1221-1239. 10.1517/14712598.2012.697149, 22731874.
10. Visone R, Croce CM. MiRNAs and cancer. Am J Pathol 2009, 174(4):1131-1138. 10.2353/ajpath.2009.080794, 2671346, 19264914.
11. Acunzo M, Visone R, Romano G, Veronese A, Lovat F, Palmieri D, Bottoni A, Garofalo M, Gasparini P, Condorelli G. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene 2011, 31(5):634-642. 3719419, 21706050.
12. Jeon HS, Lee SY, Lee EJ, Yun SC, Cha EJ, Choi E, Na MJ, Park JY, Kang J, Son JW. Combining microRNA-449a/b with a HDAC inhibitor has a synergistic effect on growth arrest in lung cancer. Lung Cancer 2012, 76(2):171-176. 10.1016/j.lungcan.2011.10.012, 22078727.
13. Zhang J-G, Wang J-J, Zhao F, Liu Q, Jiang K, Yang G-H. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 2010, 411(11):846-852.
14. Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K, Gefen N, Izraeli S, Rechavi G, Pass H. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009, 27(12):2030-2037. 10.1200/JCO.2008.19.4134, 19273703.
15. Liu X, Sempere LF, Guo Y, Korc M, Kauppinen S, Freemantle SJ, Dmitrovsky E. Involvement of microRNAs in lung cancer biology and therapy. Transl Res 2011, 157(4):200-208. 10.1016/j.trsl.2011.01.001, 3072599, 21420030.
16. Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, Shu Y. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother 2010, 64(6):399-408. 10.1016/j.biopha.2010.01.018, 20363096.
17. Yu F, Deng H, Yao H, Liu Q, Su F, Song E. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 2010, 29(29):4194-4204. 10.1038/onc.2010.167, 20498642.
18. Feber A, Wilson GA, Zhang L, Presneau N, Idowu B, Down TA, Rakyan VK, Noon LA, Lloyd AC, Stupka E. Comparative methylome analysis of benign and malignant peripheral nerve sheath tumors. Genome Res 2011, 21(4):515-524. 10.1101/gr.109678.110, 3065699, 21324880.
19. Quintavalle C, Donnarumma E, Iaboni M, Roscigno G, Garofalo M, Romano G, Fiore D, De Marinis P, Croce CM, Condorelli G. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. Oncogene 2012, 31:4001-4008.
20. Guan P, Yin Z, Li X, Wu W, Zhou B. Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues. J Exp Clin Cancer Res 2012, 31(1):54. 10.1186/1756-9966-31-54, 3502083, 22672859.
21. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005, 33(20):179.
22. Li J, Kong X, Zhang J, Luo Q, Li X, Fang L. MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer. Cancer Cell Int 2013, 13(1):7. 10.1186/1475-2867-13-7, 3599806, 23374284.
23. You X, Liu F, Zhang T, Li Y, Ye L, Zhang X. Hepatitis B virus X protein upregulates oncogene Rab18 to result in the dysregulation of lipogenesis and proliferation of hepatoma cells. Carcinogenesis 2013, 34(7):1644-1652. 10.1093/carcin/bgt089, 23471881.
24. Helwak A, Kudla G, Dudnakova T, Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013, 153(3):654-665. 10.1016/j.cell.2013.03.043, 3650559, 23622248.
25. Liang Y. An expression meta-analysis of predicted microRNA targets identifies a diagnostic signature for lung cancer. BMC Med Genet 2008, 1(1):61.
26. Ouzounova M, Vuong T, Ancey P-B, Ferrand M, Durand G, Kelm FL-C, Croce C, Matar C, Herceg Z, Hernandez-Vargas H. MicroRNA miR-30 family regulates non-attachment growth of breast cancer cells. BMC Genomics 2013, 14(1):139. 10.1186/1471-2164-14-139, 3602027, 23445407.
27. Liu C, Tang DG. MicroRNA regulation of cancer stem cells. Cancer Res 2011, 71(18):5950-5954. 10.1158/0008-5472.CAN-11-1035, 3177108, 21917736.
28. Martinez I, Cazalla D, Almstead LL, Steitz JA, DiMaio D. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci 2011, 108(2):522-527. 10.1073/pnas.1017346108, 3021067, 21187425.
29. Chia WJ, Tang BL. Emerging roles for Rab family GTPases in human cancer. Biochim Biophys Acta 2009, 1795(2):110-116.
30. Tang BL, Ng EL. Rabs and cancer cell motility. Cell Motil Cytoskeleton 2009, 66(7):365-370. 10.1002/cm.20376, 19418559.
31. Cheng KW, Lahad JP, Gray JW, Mills GB. Emerging role of RAB GTPases in cancer and human disease. Cancer Res 2005, 65(7):2516-2519. 10.1158/0008-5472.CAN-05-0573, 15805241.
32. Bem D, Yoshimura S-I, Nunes-Bastos R, Bond FF, Kurian MA, Rahman F, Handley MTW, Hadzhiev Y, Masood I, Straatman-Iwanowska AA. Loss-of-function mutations in RAB18 cause Warburg micro syndrome. Am J Hum Genet 2011, 88(4):499-507. 10.1016/j.ajhg.2011.03.012, 3071920, 21473985.
33. Behrends U, Schneider I, Rössler S, Frauenknecht H, Golbeck A, Lechner B, Eigenstetter G, Zobywalski C, Müller-Weihrich S, Graubner U. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. Int J Cancer 2003, 106(2):244-251. 10.1002/ijc.11208, 12800201.